To this end, we used the human chronic myeloid leukemia cell line K562, which displays higher levels of endogenous KDM4C in comparison to the non-malignant HEK293 cell line. This evidence concerns the gene KDM4C and chronic myelogenous leukemia, BCR-ABL1 positive.